The Food and Drug Administration has quietly approved a generic form of mifepristone, one of the two medications used in most abortions in the U.S., and pro-lifers are sounding an alarm about the dangers of the pill.

The FDA announced in a letter to drugmaker Evita Solutions LLC., that it signed off on a low-cost version of mifepristone.

That's the drug most commonly used in chemical abortions, and it is now reportedly being used in more than 6 in 10 abortions in the United States.

The drugmaker previously sent an abbreviated drug application (ANDA) for mifepristone to the FDA on October 1, 2021. In the letter, the FDA outlined that the company could begin manufacturing generic 200 mg mifepristone tablets as of September 30, 2025.

"We have completed the review of this ANDA and have c

See Full Page